Literature DB >> 7753045

Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant.

N Venkatesan1, G Chandrakasan.   

Abstract

Cyclophosphamide causes lung injury in rats through its ability to generate free radicals with subsequent endothelial and epithelial cell damage. In order to observe the protective effects of a potent anti-inflammatory antioxidant, curcumin (diferuloyl methane) on cyclophosphamide-induced early lung injury, healthy, pathogen free male Wistar rats were exposed to 20 mg/100 g body weight of cyclophosphamide, intraperitoneally as a single injection. Prior to cyclophosphamide intoxication oral administration of curcumin was performed daily for 7 days. At various time intervals (2, 3, 5 and 7 days post insult) serum and lung samples were analyzed for angiotensin converting enzyme, lipid peroxidation, reduced glutathione and ascorbic acid. Bronchoalveolar lavage fluid was analyzed for biochemical constituents. The lavage cells were examined for lipid peroxidation and glutathione content. Excised lungs were analyzed for antioxidant enzyme levels. Biochemical analyses revealed time course increases in lavage fluid total protein, albumin, angiotensin converting enzyme (ACE), lactate dehydrogenase, N-acetyl-beta-D-glucosaminidase, alkaline phosphatase, acid phosphatase, lipid peroxide levels and decreased levels of glutathione (GSH) and ascorbic acid 2, 3, 5 and 7 days after cyclophosphamide intoxication. Increased levels of lipid peroxidation and decreased levels of glutathione and ascorbic acid were seen in serum, lung tissue and lavage cells of cyclophosphamide groups. Serum angiotensin converting enzyme activity increased which coincided with the decrease in lung tissue levels. Activities of antioxidant enzymes were reduced with time in the lungs of cyclophosphamide groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753045     DOI: 10.1007/BF00928916

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes.

Authors:  A C Reddy; B R Lokesh
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

2.  Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57/B16 and ICR mice.

Authors:  S Kanekal; L Fraiser; J P Kehrer
Journal:  Toxicol Appl Pharmacol       Date:  1992-05       Impact factor: 4.219

3.  Modification of certain inflammation-induced biochemical changes by curcumin.

Authors:  R Srivastava; R C Srimal
Journal:  Indian J Med Res       Date:  1985-02       Impact factor: 2.375

4.  Pulmonary histological appearances in fatal paraquat poisoning.

Authors:  G Rebello; J K Mason
Journal:  Histopathology       Date:  1978-01       Impact factor: 5.087

5.  Guinea pig ozone-induced airway hyperreactivity is associated with increased N-acetyl-beta-D-glucosaminidase activity in bronchoalveolar lavage fluid.

Authors:  D B Lew; V Chodimella; C G Murlas
Journal:  Lung       Date:  1990       Impact factor: 2.584

6.  Sclerosing alveolitis induced by cyclophosphamide. Ultrastructural observations on alveolar injury and repair.

Authors:  V E Gould; J Miller
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

7.  Biochemical indices of cyclophosphamide-induced lung toxicity.

Authors:  J M Patel; E R Block; C I Hood
Journal:  Toxicol Appl Pharmacol       Date:  1984-10       Impact factor: 4.219

8.  Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung.

Authors:  J M Patel; E R Block
Journal:  Exp Lung Res       Date:  1985       Impact factor: 2.459

9.  Preliminary study on antirheumatic activity of curcumin (diferuloyl methane).

Authors:  S D Deodhar; R Sethi; R C Srimal
Journal:  Indian J Med Res       Date:  1980-04       Impact factor: 2.375

10.  Cyclophosphamide-induced lung damage in mice: protection by a small preliminary dose.

Authors:  C H Collis; C M Wilson; J M Jones
Journal:  Br J Cancer       Date:  1980-06       Impact factor: 7.640

View more
  10 in total

1.  Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice.

Authors:  P Pratheeshkumar; Girija Kuttan
Journal:  Inflammopharmacology       Date:  2010-05-15       Impact factor: 4.473

Review 2.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

3.  Thymoquinone attenuates cyclophosphamide-induced pulmonary injury in rats.

Authors:  Ghada M Suddek; Nora A Ashry; Nariman M Gameil
Journal:  Inflammopharmacology       Date:  2012-11-30       Impact factor: 4.473

4.  Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome.

Authors:  Sreedevi Avasarala; Fangfang Zhang; Guangliang Liu; Ruixue Wang; Steven D London; Lucille London
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  Anti-cancer natural products isolated from chinese medicinal herbs.

Authors:  Wen Tan; Jinjian Lu; Mingqing Huang; Yingbo Li; Meiwan Chen; Guosheng Wu; Jian Gong; Zhangfeng Zhong; Zengtao Xu; Yuanye Dang; Jiajie Guo; Xiuping Chen; Yitao Wang
Journal:  Chin Med       Date:  2011-07-22       Impact factor: 5.455

Review 6.  Curcumin and Health.

Authors:  Mario Pulido-Moran; Jorge Moreno-Fernandez; Cesar Ramirez-Tortosa; Mcarmen Ramirez-Tortosa
Journal:  Molecules       Date:  2016-02-25       Impact factor: 4.411

7.  Curcumin Alleviates IUGR Jejunum Damage by Increasing Antioxidant Capacity through Nrf2/Keap1 Pathway in Growing Pigs.

Authors:  Enfa Yan; Jiaqi Zhang; Hongli Han; Jiamin Wu; Zhending Gan; Chengheng Wei; Lili Zhang; Chao Wang; Tian Wang
Journal:  Animals (Basel)       Date:  2019-12-24       Impact factor: 2.752

8.  Enhanced curcumin loaded nanocellulose: a possible inhalable nanotherapeutic to treat COVID-19.

Authors:  Thennakoon M Sampath U Gunathilake; Yern Chee Ching; Hiroshi Uyama; Nguyen Dai Hai; Cheng Hock Chuah
Journal:  Cellulose (Lond)       Date:  2022-01-04       Impact factor: 6.123

9.  Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma.

Authors:  A Khedhaier; S Remadi; M Corbex; S B Ahmed; N Bouaouina; S Mestiri; R Azaiez; A N Helal; L Chouchane
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

Review 10.  Potential effects of curcumin in the treatment of COVID-19 infection.

Authors:  Fatemeh Zahedipour; Seyede Atefe Hosseini; Thozhukat Sathyapalan; Muhammed Majeed; Tannaz Jamialahmadi; Khalid Al-Rasadi; Maciej Banach; Amirhossein Sahebkar
Journal:  Phytother Res       Date:  2020-06-23       Impact factor: 6.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.